NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹273 Cr | ₹363 Cr | ₹165 Cr | ₹404 Cr | ₹266 Cr |
What is the latest Total Debt ratio of NATCO PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹273 Cr |
| Mar2024 | ₹363 Cr |
| Mar2023 | ₹165 Cr |
| Mar2022 | ₹404 Cr |
| Mar2021 | ₹266 Cr |
How is Total Debt of NATCO PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹273 Cr | -24.81 | |
| Mar2024 | ₹363 Cr | 120.12 | |
| Mar2023 | ₹165 Cr | -59.16 | |
| Mar2022 | ₹404 Cr | 51.99 | |
| Mar2021 | ₹266 Cr | - | |
Compare Total Debt of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,954.2 Cr | 0.9% | 6.8% | 0.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 0.9% |
6.8% |
0.6% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses